Joshua F. Do Goldsmith
Joshua F. Do Goldsmith has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Steven R. Tahan
Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston Massachusetts USA
2 shared publications - Christos Tsokos
Beth Israel Deaconess Medical Center Boston Massachusetts USA
1 shared publication - Emily Anne Towery
Beth Israel Deaconess Medical Center Boston Massachusetts USA
1 shared publication - Emily Ryan
Beth Israel Deaconess Medical Center Boston Massachusetts USA
1 shared publication - Hemant Varma
Beth Israel Deaconess Medical Center Boston Massachusetts USA
1 shared publication - Kanchan Kantekure
Beth Israel Deaconess Medical Center Boston Massachusetts USA
1 shared publication
Latest Publications
- 17 November 2026
- Published by Wiley in Histopathology
Diagnosis of infectious disease pathology on whole slide images: a multi‐platform evaluation with implications for digital laboratory practice
Purpose: Adoption of whole slide imaging (WSI) is accelerating across anatomic pathology practices, yet there is a lack of evidence guiding its use for infectious disease diagnoses. WSI systems usually operate at a maximum of 40X magnification without z‐plane depth, appropriately raising concerns about detecting microorganisms. Methods: We assembled a 15‐case panel (with immunohistochemistry [IHC]/special stains where indicated) spanning bacterial, viral, parasitic and fungal infections of various organ systems, including five organism‐negative ‘controls’. An infectious disease pathologist independently reviewed all glass slides to confirm the diagnoses. Eight board‐certified pathologists reviewed cases (blinded to diagnoses) scanned on one of four high‐throughput scanner platforms (Philips SG300, Hamamatsu S360, Pramana (Spectral HT2) and Leica GT450 designated A‐D (not in order), two pathologists/platform). As a control group, two additional pathologists reviewed the same cases on glass slides. Additionally, in an attempt to compare image quality among the four WSI platforms, 10 pathologists (blinded to the platform) rated image quality from side‐by‐side screenshots in 12 representative cases. Results: Aggregate diagnostic scores were: Scanner A: 78%, Scanner D: 71%, Scanner C: 69% and Scanner B: 65%, (mean 71%) vs. 79% for glass‐slide reviewers. Intra‐platform variability between the two pathologists on the same scanner (up to 23% on platform D) exceeded inter‐platform differences. WSI reviewers performed near‐equivalently to glass‐slide reviewers for large organisms (92% vs. 89%) but lower for small/low‐burden organisms (36% vs. 63%). Conclusions: Diagnostic performance on WSI for infectious disease pathology in this exploratory study varied primarily with organism size and burden, not by platform‐specific image quality differences. WSI is non‐inferior to glass for large organisms, but glass slide review may be superior for small (and low burden) organisms.
- 17 November 2026
- Published by Wiley in Histopathology
Diagnosis of infectious disease pathology on whole slide images: a multi‐platform evaluation with implications for digital laboratory practice
Purpose: Adoption of whole slide imaging (WSI) is accelerating across anatomic pathology practices, yet there is a lack of evidence guiding its use for infectious disease diagnoses. WSI systems usually operate at a maximum of 40X magnification without z‐plane depth, appropriately raising concerns about detecting microorganisms. Methods: We assembled a 15‐case panel (with immunohistochemistry [IHC]/special stains where indicated) spanning bacterial, viral, parasitic and fungal infections of various organ systems, including five organism‐negative ‘controls’. An infectious disease pathologist independently reviewed all glass slides to confirm the diagnoses. Eight board‐certified pathologists reviewed cases (blinded to diagnoses) scanned on one of four high‐throughput scanner platforms (Philips SG300, Hamamatsu S360, Pramana (Spectral HT2) and Leica GT450 designated A‐D (not in order), two pathologists/platform). As a control group, two additional pathologists reviewed the same cases on glass slides. Additionally, in an attempt to compare image quality among the four WSI platforms, 10 pathologists (blinded to the platform) rated image quality from side‐by‐side screenshots in 12 representative cases. Results: Aggregate diagnostic scores were: Scanner A: 78%, Scanner D: 71%, Scanner C: 69% and Scanner B: 65%, (mean 71%) vs. 79% for glass‐slide reviewers. Intra‐platform variability between the two pathologists on the same scanner (up to 23% on platform D) exceeded inter‐platform differences. WSI reviewers performed near‐equivalently to glass‐slide reviewers for large organisms (92% vs. 89%) but lower for small/low‐burden organisms (36% vs. 63%). Conclusions: Diagnostic performance on WSI for infectious disease pathology in this exploratory study varied primarily with organism size and burden, not by platform‐specific image quality differences. WSI is non‐inferior to glass for large organisms, but glass slide review may be superior for small (and low burden) organisms.
- 11 October 2022
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 46 (12) , 1642-1649
Clonal-pattern Seborrheic Keratosis
Seborrheic keratosis is a benign epidermal tumor. Seborrheic keratosis with clonal pattern (CPSK) displays histologic features distinct from other subtypes of SK (non-CPSK). We sought to quantitatively assess the risk of recurrence and progression to squamous cell carcinoma (SCC), either in situ or invasive, of incompletely excised CPSKs. We studied all 244 cases from 238 patients of “seborrheic keratosis, clonal pattern” diagnosed in our institution over a 10-year period (2008-2018). Demographic, clinical, pathologic, and follow-up data were gleaned from electronic health records. Following glass slide review, CPSK lesions were divided into 2 groups: CPSK with cytologic atypia and CPSK without cytologic atypia. For comparison, 107 non-CPSKs were studied as controls. The minimum follow-up period was 2 years (median=4 y). All lesions were incompletely excised. Eighteen of 244 CPSKs (7.4%) recurred at or adjacent to the site of initial partial removal compared with 1.9% of non-CPSKs. Five of the 18 (28%) recurrent CPSKs recurred as CPSK, 11 (61%) as SCC in situ, and 3 (17%) as invasive SCC. The mean time to recurrence was 3.1 years. Two non-CPSKs recurred as non-CPSKs. Overall CPSKs were more likely to recur than non-CPSKs (P=0.04). CPSKs with atypia were more likely to recur than CPSKs without atypia (P=0.03). The upgrade rate to SCC at least in situ of all recurrent CPSK lesions with atypia was 78%. Our results suggest that pathologists should report the presence of clonal pattern when observed in seborrheic keratoses, indicate the presence of atypia, and provide lesional margin assessment.
- 11 October 2022
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 46 (12) , 1642-1649
Clonal-pattern Seborrheic Keratosis
Seborrheic keratosis is a benign epidermal tumor. Seborrheic keratosis with clonal pattern (CPSK) displays histologic features distinct from other subtypes of SK (non-CPSK). We sought to quantitatively assess the risk of recurrence and progression to squamous cell carcinoma (SCC), either in situ or invasive, of incompletely excised CPSKs. We studied all 244 cases from 238 patients of “seborrheic keratosis, clonal pattern” diagnosed in our institution over a 10-year period (2008-2018). Demographic, clinical, pathologic, and follow-up data were gleaned from electronic health records. Following glass slide review, CPSK lesions were divided into 2 groups: CPSK with cytologic atypia and CPSK without cytologic atypia. For comparison, 107 non-CPSKs were studied as controls. The minimum follow-up period was 2 years (median=4 y). All lesions were incompletely excised. Eighteen of 244 CPSKs (7.4%) recurred at or adjacent to the site of initial partial removal compared with 1.9% of non-CPSKs. Five of the 18 (28%) recurrent CPSKs recurred as CPSK, 11 (61%) as SCC in situ, and 3 (17%) as invasive SCC. The mean time to recurrence was 3.1 years. Two non-CPSKs recurred as non-CPSKs. Overall CPSKs were more likely to recur than non-CPSKs (P=0.04). CPSKs with atypia were more likely to recur than CPSKs without atypia (P=0.03). The upgrade rate to SCC at least in situ of all recurrent CPSK lesions with atypia was 78%. Our results suggest that pathologists should report the presence of clonal pattern when observed in seborrheic keratoses, indicate the presence of atypia, and provide lesional margin assessment.
- 12 May 2020
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 47 (10) , 960-966
Intralymphatic histiocytosis in healing cellulitis: Case report and review of the literature
Intralymphatic histiocytosis (ILH) is a rare skin benign condition observed in a variety of inflammatory settings. It is characterized by the presence of ectatic dermal lymphatic vessels containing aggregates of histiocytes. Associated conditions that have been identified include rheumatoid arthritis, metallic orthopedic implants, inflammatory bowel disease, and malignancies of the breast, skin, and colon. Some cases with no attributable underlying cause have been described. The pathophysiology of ILH is not well understood. It has been proposed that it may represent macrophage migration during immune activation. Herein, we present the first description of ILH observed in the healing phase of cellulitis on the skin of the breast. Awareness of this possibility is important when the diagnosis of intravascular carcinomatosis is being considered.
- 12 May 2020
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 47 (10) , 960-966
Intralymphatic histiocytosis in healing cellulitis: Case report and review of the literature
Intralymphatic histiocytosis (ILH) is a rare skin benign condition observed in a variety of inflammatory settings. It is characterized by the presence of ectatic dermal lymphatic vessels containing aggregates of histiocytes. Associated conditions that have been identified include rheumatoid arthritis, metallic orthopedic implants, inflammatory bowel disease, and malignancies of the breast, skin, and colon. Some cases with no attributable underlying cause have been described. The pathophysiology of ILH is not well understood. It has been proposed that it may represent macrophage migration during immune activation. Herein, we present the first description of ILH observed in the healing phase of cellulitis on the skin of the breast. Awareness of this possibility is important when the diagnosis of intravascular carcinomatosis is being considered.